R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

Precision medicine: AZ's Ruth March on its next steps

AstraZeneca’s senior vice-president and head of precision medicine, research & development, Ruth March, has been central to the company’s transformed approach to personalised treatment.

Views & Analysis

Rethinking drug discovery

George Underwood speaks to R&D veteran Dr Paul-Peter Tak about how the drug discovery model needs to change.

Views & Analysis

R&D round-up: Non-opioid painkiller space heats up

As the MHRA announced that it would be convening an Expert Working

R&D

Innovating in clinical trial recruitment

Clinical trial recruitment is in crisis, with 80% of trials failing to recruit the required number of patients on time.

Views & Analysis

Pharma’s apprentice army is sculpting the future

A skills gap has been threatening to knock the shine off the UK biotechnology sector’s sparkling reputation for the last few years.

Views & Analysis

Women in Science: Shao-Lee Lin

Horizon Pharma's executive vice president, head of research and development, and chief scientific officer talks to pharmaphorum about what inspires her in life sciences,

Precision medicine: AZ's Ruth March on its next steps

Rethinking drug discovery

R&D round-up: Non-opioid painkiller space heats up

Innovating in clinical trial recruitment

Pharma’s apprentice army is sculpting the future

Women in Science: Shao-Lee Lin

On the benefits of earlier oncological intervention, with Jo...

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks